Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Bone & Joint
  4. Osteoporosis
  5. Treatment

Treatment

  • Fibromyalgia (23)
  • Fractures (11)
  • Gout (29)
  • Lupus (2)
  • Musculoskeletal (20)
  • Orthopedics (10)
  • Osteoarthritis (88)
  • Osteopathy (2)
  • Osteoporosis (155)
    • Bisphosphonates (24)
    • Drug Toxicity (47)
    • Natural Medicines/Supplements (28)
    • Prevention/Screening (41)
    • Treatment (66)
  • Other (27)
  • Resources (159)
  • Rheumatoid Arthritis (63)
31 - 45 of 66 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
PL Voices: Choosing a Treatment for Osteoporosis July 2012
Article: how long to use a bisphosphonate for osteoporosis and what to use instead July 2012
Article: more controversy about how long patients should take bisphosphonates (Fosamax, etc) for osteoporosis November 2011
PL Voices: Bisphosphonates for Osteoporosis November 2011
Commentary: Safety of Long-Term Bisphosphonate Therapy November 2011
Article: new concerns that bisphosphonates might increase the risk of esophageal cancer and femur fractures October 2010
Other: FDA Podcast: Bisphosphonates and Risk of Esophageal Cancer (July 2011) October 2010
Commentary: Bisphosphonates: Esophageal Cancer and Other Safety Concerns October 2010
Article: new injectable monoclonal antibody for osteoporosis called Prolia (PRO-lee-a, denosumab) August 2010
Guideline: Prevention and Treatment of Osteoporosis (NOF) (2013) August 2010
Commentary: New Drug: Prolia (Denosumab) August 2010
Guideline: Diagnosis and Treatment of Osteoporosis (ICSI) (Updated July 2013) August 2010
Guideline: Management of Osteoporosis in Postmenopausal Women (NAMS) (2010) August 2010
Article: oral bisphosphonates (Fosamax, etc) might decrease the risk of breast cancer January 2010
Article: how long women should take a bisphosphonate for osteoporosis December 2009
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved